Back
Aquestive Therapeutics Quote, Financials, Valuation and Earnings
Buy
51
AQST
Aquestive Therapeutics
Last Price:
3.10
Seasonality Move:
9.86%
7 Day Trial
ALL ACCESS PASS
$
7
Aquestive Therapeutics Price Quote
$3.10
-0.01 (-5.49%)
(Updated: May 18, 2024 at 5:37 AM ET)
Aquestive Therapeutics Key Stats
Buy
51
Aquestive Therapeutics (AQST)
is a Buy
Day range:
$3.10 - $3.32
52-week range:
$1.25 - $6.23
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.97
P/B ratio:
0%
Volume:
834.7K
Avg. volume:
2.2M
1-year change:
51.71%
Market cap:
$283.1M
Revenue:
$50.6M
EPS:
$-0.43
How Much Does Aquestive Therapeutics Make?
-
How Much Are Aquestive Therapeutics's Sales Annually?
AQST Revenues are $50.6M -
How Much Profit Does Aquestive Therapeutics's Make A Year?
AQST net income is -$7.9M
Is Aquestive Therapeutics Growing As A Company?
-
What Is Aquestive Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Aquestive Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aquestive Therapeutics Stock Price Performance
-
Did Aquestive Therapeutics Stock Go Up Last Month?
Aquestive Therapeutics share price went down by -20.66% last month -
Did AQST's Share Price Rise Over The Last Year?
AQST share price rose by 51.71% over the past 1 year
What Is Aquestive Therapeutics 52-Week High & Low?
-
What Is Aquestive Therapeutics’s 52-Week High Share Price?
Aquestive Therapeutics has traded as high as $6.23 over the past 52 weeks -
What Is Aquestive Therapeutics’s 52-Week Low Share Price?
Aquestive Therapeutics has traded as low as $1.25 over the past 52 weeks
Aquestive Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aquestive Therapeutics?
-
How Much Debt Does Aquestive Therapeutics Have?
Total long term debt quarterly is $28.8M -
How Much Cash Does Aquestive Therapeutics Have?
Cash and short term investments quarterly total is $95.2M -
What Is Aquestive Therapeutics’s Book Value Per Share?
Book value per share is -0.40
Is Aquestive Therapeutics Cash Flow Positive?
-
What Is AQST Cash Flow From Operations?
Cash flow from operations (TTM) is -$25.6M -
What Is Aquestive Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $94.9M -
What Is Aquestive Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$1M
Aquestive Therapeutics Return On Invested Capital
Data Unavailable
Aquestive Therapeutics Earnings Date & Stock Price
-
What Is Aquestive Therapeutics's Stock Price Today?
A single share of AQST can be purchased today for 3.11 -
What Is Aquestive Therapeutics’s Stock Symbol?
Aquestive Therapeutics trades on the nasdaq under the ticker symbol: AQST -
When Is Aquestive Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Aquestive Therapeutics is scheduled on August 7, 2024 -
When Is AQST's next ex-dividend date?
Aquestive Therapeutics's next ex-dividend date is May 18, 2024 -
How To Buy Aquestive Therapeutics Stock?
You can buy Aquestive Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aquestive Therapeutics Competitors
-
Who Are Aquestive Therapeutics's Competitors?
Below is a list of companies who compete with Aquestive Therapeutics or are related in some way:
Aquestive Therapeutics Dividend Yield
Data Unavailable
Aquestive Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -50% |
| Revenue: | 8.25% | -1.71% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 8.61 |
| Upside from Last Price: | 176.88% |